attenuate the activity of c-di-AMP metabolism enzymes is high. Herein, we report the first small molecule inhibitor of a c-di-AMP synthase, DisA, using a coralyne-based assay.
The ability to sense the environment and communicate with coinhabitants of an ecosystem is critical for the survival of any 15 organism. Consequently intricate sensing and regulatory mechanisms have evolved in organisms to regulate physiological processes, in response to a changing environment. In 2008, Hopfner showed in a seminal paper that DisA, a Bacillus subtilis protein that controls sporulation checkpoint when DNA double 20 strand break occurs, has a nucleotide-binding domain that binds to ATP to make a novel cyclic dinucleotide, c-di-AMP. 1 It turned out that the presence of c-di-AMP signaled the presence of DNA structures that would interfere with proper chromosome segregation. Hopfner also predicted that many bacteria harbored 25 proteins that contained the diadenylate cyclase (DAC) domain and hence c-di-AMP could have a wider role in bacteria, beyond reporting DNA strand breaks. 1 The importance of Hopfner's discovery became apparent when soon thereafter many reports by other laboratories confirmed that c-di-AMP is indeed 30 produced in other bacteria, some of which are of clinical relevance.
2, 3 C-di-AMP has now been shown to control a dazzling array of processes in bacteria (see Figure 1) when c-di-AMP is introduced into the cytoplasm of eukaryotic cells, for example when intracellular pathogens secret the nucleotide or during endocytosis of bacteria, it binds to STING to elicit type I inteferon response 2, 11 . The modulation of bacterial cell wall synthesis by c-di-AMP 40 is particularly interesting because a high percentage of antibiotics, in clinical use, target components of the bacterial cell wall, suggesting that small molecules that could perturb the intracellular concentrations of c-di-AMP could synergize with antibiotics such as the β-lactams or vancomycins to kill 45 pathogenic bacteria. 12 An obvious way to reduce intracellular concentration of c-di-AMP would be to inhibit c-di-AMP synthases. High-throughput assays that could be used to monitor the production of c-di-AMP by DAC enzymes would facilitate the discovery of c-di-AMP signaling inhibitors. 50 Recently, we described a surprisingly simple detection of c-di-AMP using commercially available coralyne and halide quenchers. 13 In this assay, the fluorescence of coralyne is quenched by a bromide or iodide anion but when coralyne becomes entrapped by a supramolecular aggregate of c-di-AMP, 55 iodide can no longer quench the fluorescence and hence enhancement of fluorescence occurs only when c-di-AMP is present (see Figure 2 ). In our prior disclosure, the synthesis of cdi-AMP by DisA was monitored as an end-point assay, that is aliquots of the enzymatic reaction were taken at different time 60 points and analyzed using coralyne and KI. For high-throughput assay, this format was obviously not ideal so we wondered if we could add the coralyne and KI to the DisA reaction and monitor the progress of c-di-AMP formation in "real-time". Pleasingly, the presence of coralyne or KI did not affect the enzymatic proficiency of DisA to a great extent and so we could use the coralyne assay to screen for inhibition using a library of 1000 compounds (obtained from TimTec kinase set, and Sigma, see SI 5 for compounds ID). The Sigma compounds were randomly selected by us from the Sigma website but our selection was biased by compounds that were either drug-like or known to be kinase inhibitors.
The majority of the tested compounds, 99%, did not affect the 10 synthesis of c-di-AMP by DisA to any meaningful extent (see SI and Figure 3) . However, about 11 out of the 1000 compounds reduced the fluorescence of the coralyne assay, implying that these compounds either inhibited the DisA enzyme or competed with the synthesized c-di-AMP for binding to coralyne or both. 15 Conceivably the compounds could form a π-complex with coralyne leading to a "dark" aggregate. This would be especially true for compounds that contain heavy halogens, which are known to be fluorescence quenchers 14 . We therefore investigated the extent to which the fluorescence of coralyne was reduced by 20 the 11 apparent "hits" in the presence and absence of c-di-AMP. We also used HPLC to monitor the synthesis of c-di-AMP by DisA in the presence of the 11 apparent hits, see SI. Out of the 11 apparent hits, only one ST056083 . It therefore appears that the coralyne assay has false positives due to the direct quenching of coralyne's fluorescence by some small molecules. But this problem is not 30 unique to the coralyne assay and in fact would exist in all turnoff assays as the potential for library members to affect the fluorescence of an assay would always exist. An excellent paper by Inglese has documented the problem of false positives that arise from fluorogenic library members. 16 Nonetheless, there are 35 hardly any false-negatives. That is if the fluorescence of coralyne in the presence of a non-fluorescent inhibitor is similar to when no small molecule was added, control, then it implies that small molecule is definitely not an inhibitor. To provide support for this statement randomly selected 25 compounds that were 40 negative for the coralyne assay were retested using HPLC assay and none showed inhibition, see SI, Figure SI4 . Thus, the assay is still very useful because it reduced a large library size of 1000 to 11, which could then be investigated in detail using traditional low-throughput assays, such as HPLC and radioactive labelling.
45
Bromophenol-TH contains both a halogenated phenol and thiohydantoin groups, however it appears that the mere presence of these groups is not good enough for DisA inhibition. For example, ST003014 and ST003440 both contain thiohydantoin and haloarene/phenolic moiety yet they did not inhibit c-di-AMP 50 synthesis by DisA (see Figure 3) . Intrinsic tryptophan fluorescence can be used to monitor ligand binding to a protein if the binding event results in a change in the environment of the tryptophan. Pleasingly, the fluorescence of a tryptophan residue in DisA changed upon the addition of bromophenol-TH and so 55 we could determine the apparent K d for the bromophenol-TH/DisA complex from tryptophan fluorescence titration (see Figure 4 and Table 1) . 17 Interestingly, ST028249, which also contains bromophenolic fragment and a rhodanine moiety (which is similar to a thiohydantoin group), binds to DisA more tightly than bromophenol-TH (K d apparent of 11 vs 21 µM, Table 1 18 ) yet it is unable to inhibit c-di-AMP synthesis. Using α-32 P-ATP, we determined that the IC 50 for inhibiting 5 µM of DisA by 5 bromophenol-TH, when 50 µM of ATP is used as substrate is 56 µM (see Figure 5 ). When the ATP concentration was increased by 10-fold to 500 µM, the IC 50 only changed by a factor of 2 to 100 µM (see Figure SI6) . To eliminate the possibility that the observed inhibition is due to non-specific aggregation, we also 10 investigated the inhibition of DisA by bromophenol-TH in the presence of a surfactant, Triton X-100. Pleasingly, bromopenol-TH could still inhibit DisA in the presence of Triton X-100 (see SI, Figure SI7 ). Interestingly, bromophenol-TH does not bind to the same site as ATP because the addition of up to 1 mM ATP 15 did not abrogate the binding of bromophenol-TH to DisA (see Figure 6 and Figure SI8 ). Bromophenol-TH contains a Michael acceptor and could potentially react with nucleophiles. To investigate if conjugate addition by nucleophiles would readily occur, we performed incubation with 1 mM cysteine and 20 followed the reaction progress using UV absorbance. The UV intensity, from 250nm to 450nm, did not change after cysteine addition and remained unchanged for 1 h (see SI, Figure SI9 ), implying that nucleophilic addition to bromophenol is not facile under the assay condition. Future structure-activity relationship 25 studies are planned to optimize bromophenol-TH into a more potent inhibitor.
To guide future SAR and optimization studies, we determined the binding parameters for different fragments of bromophenol-TH, 3,5-dibromosalicylic acid, 3,5-dibromosalicylaldehyde and 30 2-thiohydantoine (see Figure 7 ). It appears that the bromophenol fragment is more important for binding to DisA than the thiohydantoine moiety (compare K d apparent of 67 µM for 3,5-dibromosalicylaldehyde with >1 mM for 2-thiohydantoine, Table  1) . 35 In conclusion, we have demonstrated that the coralyne assay for c-di-AMP detection is a powerful assay to do highthroughput screening for discovering novel c-di-AMP synthesis inhibitors. Interestingly, although we initially selected TimTec's kinase inhibitor library set for screening, hoping to uncover an Adding ATP (up to 1 mM) did not restore fluorescence intensity, indicating that bromophenol-TH is not a competitive inhibitor.
